Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Access the exclusive and authoritative pharma industry reports that only Pharma Intelligence can deliver. Encompassing a vast array of topics and disease areas, these exhaustive resources bring you the best in pharma sector reporting.
100+ Total results for product and free and sample content found
Medtech Insight
Keep current with comprehensive coverage of today’s deals and their impact on the future of the medtech landscape. Medtech Insight brings you insight and analysis of significant recent deals and what they mean for your strategy. Stay in the know with your free Quarterly Roundup.
Topic Medtech
Pharma Consulting
We are happy to announce our partnership with the American Society for Gene and Cell Therapy with the release of our first quarterly report. This report, powered by Informa Pharma Intelligence data, covers the therapeutics pipeline, most common targets and diseases, clinical trial activity and more!
Topic Cell & Gene Therapy
Trial Transparency Website
Citeline Engage Trial Transparency Website™ gives you more than just a visually appealing clinical trial website.
Topic Clinical Trials
Scrip
Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.
Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence
In Vivo
Despite the chaos felt in many other sectors during the COVID-19 pandemic, pharma IPOs experienced a banner year in 2020. Understand deal making trends and business strategies as In Vivo examines the emergence of special purpose acquisition companies (SPACs) in a data-packed infographic
Topic Business Strategies
Scrip
For Scrip’s annual preview our journalists asked over 200 industry executives and experts for their predictions of the major trends for 2021. From the pandemic, to AI, therapeutics, and the new US leadership, here’s what to watch out for – in a year with so much at stake.
Medtech Insight
As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the US medtech market can we expect to see over the next four years?
Topic Medtech
Medtech Insight
As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the medtech market can we expect to see over the next four years?
Topic Medtech
In Vivo
Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.
Topic Outlook
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
